Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Top Cited Papers
- 1 December 2006
- Vol. 127 (7) , 1323-1334
- https://doi.org/10.1016/j.cell.2006.12.007
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Policing of oncogene activity by p53Nature, 2006
- The pathological response to DNA damage does not contribute to p53-mediated tumour suppressionNature, 2006
- Temporal dissection of p53 function in vitro and in vivoNature Genetics, 2005
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- The role of apoptosis in cancer development and treatment responseNature Reviews Cancer, 2005
- Small molecules that reactivate mutant p53European Journal Of Cancer, 2003
- Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesisGenes & Development, 1999
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985